Want to join the conversation?
Drug giant $LLY said it received a positive opinion from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP) for its experimental drug ixekizumab. This is used to treat moderate-to-severe plaque psoriasis in adults.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.